LMR Partners’s Nu Skin NUS Stock Holding History

LMR Partners’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,724	Closed	-$182K	–	1481
2024 Q3	$182K	Buy	+24,724	New	+$231K	﹤0.01%	1005
2021 Q2	–	Sell	-9,170	Closed	-$485K	–	1262
2021 Q1	$485K	Buy	+9,170	New	+$500K	0.01%	647

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LMR Partners's NUS Position: Q4 2024 in Review

LMR Partners sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 24,724 shares — an estimated $182K sold.

LMR Partners first reported a position in NUS in Q1 2021 and held it in 2 quarters. The position peaked at $485K in Q1 2021. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

LMR Partners reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
LMR Partners sold 24,724 Nu Skin shares in Q4 2024, an estimated $182K.
LMR Partners first reported a position in Nu Skin in Q1 2021 and held it in 2 quarters.
LMR Partners's Nu Skin position peaked at $485K in Q1 2021.
200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.